Wenyin Shi
Expertise in
33
conditions

Dr. Wenyin Shi

Radiation Oncology
Jefferson Health
Radiation Oncology At Thomas Jefferson University Hospital
111 South 11th Street, Suite G-301, 
Philadelphia, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
33
conditions
Jefferson Health
Radiation Oncology At Thomas Jefferson University Hospital
111 South 11th Street, Suite G-301, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Wenyin Shi is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Shi is rated as an Experienced provider by MediFind in the treatment of Acromegaly. His top areas of expertise are Astrocytoma, Mycosis Fungoides, Brain Tumor, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Shi is currently accepting new patients.

His clinical research consists of co-authoring 158 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 158 articles and participated in 14 clinical trials in the study of Acromegaly.

Graduate Institution
Shanghai Medical University
Residency
University of Florida College of Medicine
Specialties
Radiation Oncology
Licenses
Radiology in PA
Board Certifications
Radiology
Radiation Oncology
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Radiation Oncology at Thomas Jefferson University Hospital
111 South 11th Street, Suite G-301, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Shi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Astrocytoma
Arteriovenous Malformation
Acromegaly
Acoustic Neuroma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Enrollment Status: Recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients
Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Radiation, Other, Procedure
Study Phase: Phase 1
A Feasibility Pilot Trial Evaluating Caloric Restriction for Oncology Research in Early Stage Breast Cancer Patients
A Feasibility Pilot Trial Evaluating Caloric Restriction for Oncology Research in Early Stage Breast Cancer Patients
Enrollment Status: Completed
Publish Date: June 06, 2025
Intervention Type: Behavioral, Radiation, Procedure, Other
Study Phase: Not Applicable
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Radiation, Drug
Study Drug: MK-3475
Study Phase: Phase 1
A Pilot Study to Evaluate the Predictive Value of Circulating Tumor DNA for Clinical Outcome in Patients With Advanced Head and Neck and Lung Cancers
A Pilot Study to Evaluate the Predictive Value of Circulating Tumor DNA for Clinical Outcome in Patients With Advanced Head and Neck and Lung Cancers
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Other
A Two-Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Cutaneous T Cell Lymphoma
A Two-Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Cutaneous T Cell Lymphoma
Enrollment Status: Withdrawn
Publish Date: May 02, 2025
Intervention Type: Drug, Radiation, Biological, Procedure
Study Phase: Phase 1
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug, Biological, Procedure, Radiation
Study Phase: Phase 2
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug, Radiation, Procedure
Study Phase: Phase 1
A Two Step Approach To Matched-Sibling Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematological Malignancies
A Two Step Approach To Matched-Sibling Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematological Malignancies
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Device
Study Phase: Phase 2
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies
A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies
Enrollment Status: Completed
Publish Date: November 17, 2022
Intervention Type: Radiation, Drug, Biological, Device, Procedure
Study Drugs: Fludarabine, Busulfan, Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil, Donor Lymphocyte Infusion
Study Phase: Phase 2
View 13 Less Clinical Trials

158 Total Publications

Contrast enhancement, G-CIMP subtype, and CDKN2A/B homozygous deletion in IDH-mutant astrocytoma.
Contrast enhancement, G-CIMP subtype, and CDKN2A/B homozygous deletion in IDH-mutant astrocytoma.
Journal: Neuro-oncology advances
Published: July 24, 2025
View All 158 Publications
Similar Doctors
Tamara A. Lacouture
Advanced in Acromegaly
Dr. Tamara A. Lacouture
Radiation Oncology
Advanced in Acromegaly
Dr. Tamara A. Lacouture
Radiation Oncology

Jefferson Radiation Oncology – Cherry Hill

2211 Chapel Ave West, Suite 103, 
Cherry Hill, NJ 
 (7.0 miles away)
856-922-4800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tamara Lacouture is a Radiation Oncologist in Cherry Hill, New Jersey. Dr. Lacouture is rated as an Advanced provider by MediFind in the treatment of Acromegaly. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Anal Cancer, and Pleuropulmonary Blastoma. Dr. Lacouture is currently accepting new patients.

Dane R. Cohen
Advanced in Acromegaly
Dr. Dane R. Cohen
Radiation Oncology
Advanced in Acromegaly
Dr. Dane R. Cohen
Radiation Oncology

Sidney Kimmel Comprehensive Cancer Center — Cherry Hill

2211 Chapel Avenue, 
Cherry Hill, NJ 
 (7.0 miles away)
856-922-5180
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dane Cohen is a Radiation Oncologist in Cherry Hill, New Jersey. Dr. Cohen is rated as an Advanced provider by MediFind in the treatment of Acromegaly. His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Pleuropulmonary Blastoma, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Cohen is currently accepting new patients.

William Ding
Advanced in Acromegaly
Dr. William Ding
Radiation Oncology
Advanced in Acromegaly
Dr. William Ding
Radiation Oncology
3311 Brunswick Pike, 
Lawrenceville, NJ 
 (34.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Ding is a Radiation Oncologist in Lawrenceville, New Jersey. Dr. Ding is rated as an Advanced provider by MediFind in the treatment of Acromegaly. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer. Dr. Ding is currently accepting new patients.

VIEW MORE ACROMEGALY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shi's expertise for a condition
ConditionClose
  • Elite
  • Astrocytoma
    Dr. Shi is
    Elite
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Brain Tumor
    Dr. Shi is
    Elite
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Glioblastoma
    Dr. Shi is
    Elite
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Glioma
    Dr. Shi is
    Elite
    . Learn about Glioma.
    See more Glioma experts
  • Mycosis Fungoides
    Dr. Shi is
    Elite
    . Learn about Mycosis Fungoides.
    See more Mycosis Fungoides experts
  • Distinguished
  • Acoustic Neuroma
    Dr. Shi is
    Distinguished
    . Learn about Acoustic Neuroma.
    See more Acoustic Neuroma experts
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Shi is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Shi is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Ependymoma
    Dr. Shi is
    Distinguished
    . Learn about Ependymoma.
    See more Ependymoma experts
  • Gliomatosis Cerebri
    Dr. Shi is
    Distinguished
    . Learn about Gliomatosis Cerebri.
    See more Gliomatosis Cerebri experts
  • Gliosarcoma
    Dr. Shi is
    Distinguished
    . Learn about Gliosarcoma.
    See more Gliosarcoma experts
View All 16 Distinguished Conditions
  • Advanced
  • Arteriovenous Malformation
    Dr. Shi is
    Advanced
    . Learn about Arteriovenous Malformation.
    See more Arteriovenous Malformation experts
  • Craniopharyngioma
    Dr. Shi is
    Advanced
    . Learn about Craniopharyngioma.
    See more Craniopharyngioma experts
  • Cutaneous T-Cell Lymphoma (CTCL)
    Dr. Shi is
    Advanced
    . Learn about Cutaneous T-Cell Lymphoma (CTCL).
    See more Cutaneous T-Cell Lymphoma (CTCL) experts
  • Gamma Knife Radiosurgery
    Dr. Shi is
    Advanced
    . Learn about Gamma Knife Radiosurgery.
    See more Gamma Knife Radiosurgery experts
  • Plasmacytoma
    Dr. Shi is
    Advanced
    . Learn about Plasmacytoma.
    See more Plasmacytoma experts
  • Pleuropulmonary Blastoma
    Dr. Shi is
    Advanced
    . Learn about Pleuropulmonary Blastoma.
    See more Pleuropulmonary Blastoma experts
View All 12 Advanced Conditions
  • Experienced
  • Adult Soft Tissue Sarcoma
    Dr. Shi is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Shi is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Anal Cancer
    Dr. Shi is
    Experienced
    . Learn about Anal Cancer.
    See more Anal Cancer experts
  • Bone Tumor
    Dr. Shi is
    Experienced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Brain Stem Cancer
    Dr. Shi is
    Experienced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
  • Breast Cancer
    Dr. Shi is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
View All 42 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.